期刊文献+

术前CT双能量成像联合血清甲状腺球蛋白水平对甲状腺乳头状癌颈部淋巴结转移的诊断价值 被引量:3

Diagnostic value of preoperative dual-energy CT imaging combined with serum thyroglobulin level in cervical lymph node metastasis of thyroid papillary carcinoma
下载PDF
导出
摘要 目的:探讨术前CT双能量成像联合血清甲状腺球蛋白(thyroglobulin,Tg)对甲状腺乳头状癌(papillary thyroid carcinoma,PTC)颈部淋巴结转移(cervical lymph node metastasis,CLNM)的诊断价值。方法:回顾性分析2019年5月至2021年10月在合肥京东方医院完成甲状腺癌根治术治疗的81例PTC患者的相关资料,患者术前均接受CT双能量成像扫描检查和血清Tg水平检测。以手术病理结果为金标准,将81例PTC患者按是否发生过CLNM分别分为CLNM组(n=34)和非颈部淋巴结转移组(non-cervical lymph node metastasis,N-CLNM;n=47)。比较两组术前Tg水平和CT双能量成像检查资料。采用受试者工作特征(receiver operator characteristic,ROC)曲线评价术前血清Tg水平、术前CT双能量成像检查以及联合诊断对PTC患者CLNM的诊断价值。结果:CLNM组术前血清Tg水平为97.85(75.01,117.51) ng/mL,明显高于N-CLNM组的71.30(41.79,92.34) ng/mL,2组比较有统计学意义(P<0.001)。CLNM组淋巴结短径长于N-CLNM组,CLNM组淋巴结短径>10 mm、钙化征、明显强化、囊性或坏死、侵犯周围组织的比例均高于N-CLNM组(均P<0.05)。ROC曲线显示:术前血清Tg水平联合术前CT双能量成像征象诊断PTC患者CLNM的曲线下面积为0.832(95%CI:0.763~0.901),灵敏度为82.41%,特异度为100.00%,均高于术前血清Tg水平、术前CT双能量成像征象单一诊断。结论:PTC患者术前血清Tg水平和CT双能量成像形态学征象均与CLNM的发生紧密相关,二者联合应用可为术前CLNM的诊断提供依据。 Objective: To investigate the value of preoperative dual-energy CT combined with serum thyroglobulin(Tg) in the diagnosis of cervical lymph node metastasis(CLNM) of thyroid papillary carcinoma(PTC).Methods: The data of 81 patients with PTC who completed radical thyroidectomy in Hefei BOE Hospital from May 2019 to October 2021 were analyzed retrospectively. All patients underwent dual-energy CT scanning and serum Tg level detection before operation. Taking the surgical and pathological results as the gold standard, 81 patients with PTC were divided into a CLNM group(34 patients with CLNM) and a N-CLNM group(47 patients without CLNM). The preoperative Tg levels and dual-energy CT examination data of the 2groups were compared. The receiver operator characteristic(ROC) curve was used to evaluate the diagnostic value of preoperative serum Tg level, preoperative dual-energy CT examination and combined diagnosis for CLNM in PTC patients.Results: The preoperative serum Tg level of the CLNM group was 97.85(75.01,117.51) ng/mL, which was significantly higher than that of the N-CLNM group [71.30(41.79,92.34) ng/mL], the difference was statistically significant(P<0.001). The short diameter of lymph nodes in the CLNM group was longer than that in the N-CLNM group, and the proportions of short diameter >10 mm, calcification, obvious enhancement, cystic or necrosis and invasion of surrounding tissues in the CLNM group were higher than those in the N-CLNM group(all P<0.05). ROC curve showed that the area under the curve of preoperative serum Tg level combined with preoperative dual-energy CT features in diagnosing CLNM in PTC patients was 0.832, 95% confidence interval was 0.763 to 0.901,the sensitivity was 82.41%, and the specificity was 100.00%, which were all higher than those of preoperative serum Tg level and preoperative dual-energy CT features alone.Conclusion: The preoperative serum Tg level and dual-energy CT morphological features of PTC patients are closely related to the occurrence of CLNM. The combined application of the serum Tg level and dual-energy CT features can provide a basis for the diagnosis of CLNM before operation.
作者 赵金影 ZHAO Jinying(Department of Imaging,Hefei BOE Hospital,Hefei 230012,China)
出处 《临床与病理杂志》 CAS 2023年第1期123-129,共7页 Journal of Clinical and Pathological Research
关键词 甲状腺乳头状癌 淋巴结转移 甲状腺球蛋白 CT双能量成像 诊断 papillary thyroid carcinoma lymph node metastasis thyroglobulin dual-energy CT diagnosis
  • 相关文献

参考文献10

二级参考文献67

  • 1中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012,28:779-797.
  • 2Mandel S J. A 64 -year -old woman with a thyroid nodule[J]. JA- MA, 2094, 292(21):2632-2642.
  • 3Hegedus L. Clinical practice. The thyroid nodule[J]. N Engl J Med,20041 351 (17)11764-17711.
  • 4Sherman S I. Thyroid carcinoma[J]. Lancet, 2003, 361(9356):501 - 511.
  • 5Cooper D S, Doherty G M, Haugen B R, et a}. Management guide- lines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2006, 16(2):109-142.
  • 6American Thyroid Association(ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper D S, Doherty G M, et al. Revised American Thyroid Association man- agement guidelines for patients with thyroid nodules and differ- entiated thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 7Haugen B R, Alexander E K, Bible K C, et al. 2015 American Thy- roid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer[J/OL].Thyroid, 201512015-10-15]. http://online.liebertpub, com/doi/10.1089/thy. 2015.0020.[published online ahead of print October 14, 2015].
  • 8Moosa M, Mazzaferri E L. Outcome of differentiated thyroid can- cer diagnosed in pregnant women[J]. J Clin Endocrinol Metab, 1997, 82(9):2862-2866.
  • 9Herzon F S, Morris D M, Segal M N, et al. Coexistent thyroid can- cer and pregnancy[J]. Arch Otolaryngol Head Neck Surg, 1994, 120(11):1191-1193.
  • 10Matsuzu K, Sugino K, Masudo K, et al. Thyroid Iobectomy for papillary thyroid cancer: long-term follow-up study of 1, 088 cases[J]. World J Surg, 2014, 38(1):68-79.

共引文献99

同被引文献25

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部